Navigation Links
Nanomaterials show unexpected strength under stress
Date:3/12/2008

In yet another twist on the strangeness of the nanoworld, researchers at the National Institute of Standards and Technology (NIST) and the University of Maryland-College Park have discovered that materials such as silica that are quite brittle in bulk form behave as ductile as gold at the nanoscale. Their results may affect the design of future nanomachines.

NIST scientists Pradeep Namboodiri and Doo-In Kim and colleagues first demonstrated* the latest incongruity between the macro and micro worlds this past fall with direct experimental evidence for nanoscale ductility. In a new paper** presented today at the March Meeting of the American Physical Society, NIST researchers Takumi Hawa and Michael Zachariah and guest researcher Brian Henz shared the insights they gained into the phenomenon through their computer simulations of nanoparticle aggregates.

At the macroscale, the point at which a material will fail or break depends on its ability to maintain its shape when stressed. The atoms of ductile substances are able to shuffle around and remain cohesive for much longer than their brittle cousins, which contain faint structural flaws that act as failure points under stress.

At the nanoscale, these structural flaws do not exist, and hence the materials are nearly perfect. In addition, these objects are so small that most of the atoms that comprise them reside on the surface. According to Namboodiri and Kim, the properties of the surface atoms, which are more mobile because they are not bounded on all sides, dominate at the nanoscale. This dominance gives an otherwise brittle material such as silica its counterintuitive fracture characteristics.

The terms brittle and ductile are macroscopic terminology, Kim says. It seems that these terms dont apply at the nanoscale.

Using an atomic force microscope (AFM), Kim and Namboodiri were able to look more closely at interfacial fracture than had been done before
'/>"/>

Contact: Mark Esser
mark.esser@nist.gov
301-975-2767
National Institute of Standards and Technology (NIST)
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. NanoMaterials Technology to Conduct Process Development Feasibility Study with US Based Emerging Pharmaceutical Company
2. Experiments reveal unexpected activity of fuel cell catalysts
3. Researchers engineer new polymers to change their stiffness and strength when exposed to liquids
4. Surface dislocation nucleation: Strength is but skin deep at the nanoscale, Penn engineers discover
5. New York Strengthens Emergency Preparedness with Cardinal Health Ventilators
6. Strengthening fluids with nanoparticles
7. SpectraScience Strengthens Leadership Team With Four Key Hires
8. Hcareers.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
9. BioSpace.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
10. JobLoft.com Strengthens Local Market Candidate Reach Through RegionalHelpWanted.com Acquisition
11. MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Nanomaterials show unexpected strength under stress
Nanomaterials show unexpected strength under stress
(Date:11/25/2009)..., BOCARATON,Fla.,Nov.25/PRNewswire/--Formanybusi....Thenation,slargestandfastestgrowingnetworkofexper...vised bioidenticalhormones has grownthenumberof ...o36physicians -andisinprogresstoaddmorephysician-o...syear. ,, Inthepastyear ,BodyLogicMDhasopened13...
(Date:11/25/2009)...EGO,Nov.25/PRNewswire-FirstCall/--ArdeaBiosciences...,Pharm.D.,presidentandchiefexecutiveofficer,willpr...ce. , ,Presentationdetailsareasfollows:,PiperJaf...cember1,2009,Time:2:00p.m.EasternTime,Location:The...://www.corporate-ir.net/ireye/,target=,_blank,tit...
(Date:11/24/2009)... The New York investment bank KTA Capi...has agreed an AU$6.7 mil convertible note private ...private placement was arranged by KTA Capital as N... New York (PRWEB) November ...nk KTA Capital, LLC ("KTA Capital") has ...
(Date:11/24/2009)...UIS,Nov.24/PRNewswire-FirstCall/--Sigma-AldrichCor...OMXconferenceonTuesday,December1stat1:45PMGMTinLon...audiobroadcastovertheInternetavailableat http://i...ickthe"Webcast"icontoaccessthisfile. ,, About...andHighTechnologycompany.Itschemicalandbiochemical...
Breaking Biology Technology:Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
...and product pipeline, BOTHELL, WA and VANCOUVER, ...euticals, Inc. (NASDAQ: OGXI ), a biopharmaceutic...cialization of new therapies that address,unmet ne...udited financial,results for the third quarter and...rter 2008 Financial Results, On August 21, 2008, ...
...hua-PRNewswire/ -- Simcere Pharmaceutical,Group (N...f branded generic,pharmaceuticals and innovative a...China market, announced today its participation in... 2008. The conference will be held at,the Mandarin...cere,s chief financial officer, Frank Zhigang Zhao...
...0 InspireMD, developers of,the novel MGuard(TM) c...TM),was successfully implanted in a complex lesion...erformed by Dr. Dariusz Dudek and was broadcast,fr...fast Meeting Symposium,"A New Approach to Treating...as met with great enthusiasm and excitement. Some ...
Other Biology Technology:OncoGenex Reports Third Quarter Financial Results 2OncoGenex Reports Third Quarter Financial Results 3OncoGenex Reports Third Quarter Financial Results 4OncoGenex Reports Third Quarter Financial Results 5OncoGenex Reports Third Quarter Financial Results 6OncoGenex Reports Third Quarter Financial Results 7OncoGenex Reports Third Quarter Financial Results 8OncoGenex Reports Third Quarter Financial Results 9Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008 2MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008 2MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008 3MGuard(TM), InspireMD's Novel Coronary Stent System, was Celebrated by World Leading Interventional Cardiologists at the Transcatheter Cardiovascular Therapeutics (TCT) in Washington DC, USA, October 12-17 2008 4
(Date:11/25/2009)...he course of a lifetime, the heart pumps some 250 ...rder to do this, the muscle fibers of the heart ha...ded by Dr. Wolfgang Rottbauer, vice chair of the D... Hospital (Chairman: Prof. Dr. H. A. Katus), has d...ability of the smallest muscular unit, the sarcome...
(Date:11/24/2009)...ousands of years it has been prescribed by traditi...s from headaches and stomach pain to fever and flu...tle University have been able to scientifically pr...ta otherwise known as Brazilian mint. , Testing...m led by researcher Graciela Rocha was able to sho...
(Date:11/24/2009)...ists have crystallised a protein that may help gut...protein could be used by probiotic producers to id...it to people. , "Probiotics need to interact with... and if they attach to surfaces in the gut they ar... their activity," says Dr Nathalie Juge from the I...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Got a pain? -- Have a cup of Brazilian mint 2A sticky solution for identifying effective probiotics 2New PICC Mimics Nature 50488 1New PICC Mimics Nature 50488 2Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 1Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 2Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 3Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 4Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 5Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 6Stemedica Discovers Significant Breakthrough in the Use of Stem Cells and Stem Cell Factors for the Treatment of Retinal Degeneration 50484 7Press Ganey Launches Community Image Solution 50480 1Press Ganey Launches Community Image Solution 50480 2Press Ganey Launches Community Image Solution 50480 3
.... , Infectious proteins known as prions have bee...E). The culprits are "incorrectly folded" proteins... bases for such prion diseases are not yet fully u...others are not? A team headed by Beat Meier (ETH Z...f Bordeaux, France) has examined two different for...
... Montreal, 13 June 2008 Researchers at the McG...sity and the University of British Columbia (UBC) ... cause an increase in serious adverse events, but ...s adverse events. , Several drugs containing com...noids, are available for medical purposes in Canad...
... discovered that a protein previously shown to hav...he formation of cysts in Autosomal Dominant Polycy...n life-threatening genetic diseases and has shown...isease in mice. , The discovery was published ...ine yesterday. , The team showed that a pro-in...
Other Biology News:Tracking prions 2Medicines derived from cannabis: a review of adverse events 2Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment 2
...neral description: Dish uses include large-scale c...s, hybridizations. Compatible with PBA Flexys TM ... CLS number is a new product number, created to ea...availability yet, please order under the old Sigma...
Mouse Anti-beta II Tubulin Monoclonal Antibody, Unconjugated, Clone 7B9 from Abcam
Mouse Anti-Desmoplakin I & II Monoclonal Antibody, Unconjugated, Clone DP2.15 from Meridian Life Science, Inc.
BD Biocoat Matrigel Matrix Thin Layer 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Biology Products: